Results 241 to 250 of about 178,293 (355)

Marked platelet transfusion refractoriness caused by anti-HLA-I and anti-HPA-5b antibodies: A case report. [PDF]

open access: yesMedicine (Baltimore)
Wang Y   +8 more
europepmc   +1 more source

Cancer‐Associated Fibroblasts: Origin, Classification, Tumorigenicity, and Targeting for Cancer Therapy

open access: yesMedComm, Volume 6, Issue 11, November 2025.
This review explores the multifaceted roles of cancer‐associated fibroblasts (CAFs) in tumor biology. It examines their diverse origins, dynamic activation via signaling pathways, and spatial–temporal heterogeneity, proposing an updated classification of eight distinct CAF subtypes. The review highlights CAFs' contributions to tumor growth, metastasis,
Chang Fan   +4 more
wiley   +1 more source

Antimalarial potential of Matricaria chamomilla-derived MgO nanoparticles against Plasmodium falciparum strains: an experimental study. [PDF]

open access: yesBMC Complement Med Ther
Farzaneh Z   +9 more
europepmc   +1 more source

Chloroquine resistant Plasmodium falciparum malaria in Zimbabwe. [PDF]

open access: bronze, 1986
Susan Mutambu   +2 more
openalex   +1 more source

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19

open access: yesLancet. Infectious Diseases (Print), 2020
N. Principi, S. Esposito
semanticscholar   +1 more source

Cordycepin Targets HRD1 to Promote Cancer Cell PD‐L1 Ubiquitin–Proteasome Degradation and Increase Antitumor Immunity

open access: yesMedComm, Volume 6, Issue 11, November 2025.
Using an activity‐based tracking approach, our study revealed that the component in Cordyceps militaris extract (CME) that reduces PD‐L1 activity is cordycepin, which demonstrates potential as an immune checkpoint inhibitor for colorectal cancer. Cordycepin targets HRD1, leading to PD‐L1 protein degradation via the ubiquitin–proteasome pathway, which ...
Xiangxin Geng   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy